tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Opus Genetics announces FDA clearance of IND application for OPGx-BEST1
PremiumThe FlyOpus Genetics announces FDA clearance of IND application for OPGx-BEST1
21d ago
Opus Genetics: Promising Clinical Trials and Strategic Partnerships Drive Buy Rating
Premium
Ratings
Opus Genetics: Promising Clinical Trials and Strategic Partnerships Drive Buy Rating
24d ago
Opus Genetics reports Q2 EPS (12c) vs (30c) last year
Premium
The Fly
Opus Genetics reports Q2 EPS (12c) vs (30c) last year
26d ago
Opus Genetics: Promising Developments and Strong Pipeline Justify Buy Rating
PremiumRatingsOpus Genetics: Promising Developments and Strong Pipeline Justify Buy Rating
2M ago
Opus Genetics Announces Positive Phase 3 Trial Results
Premium
Company Announcements
Opus Genetics Announces Positive Phase 3 Trial Results
2M ago
Opus Genetics’ Phentolamine Ophthalmic Solution meets primary Phase 3 endpoint
Premium
The Fly
Opus Genetics’ Phentolamine Ophthalmic Solution meets primary Phase 3 endpoint
2M ago
Opus Genetics’ Ryzumvi Shows Promising Phase 3 Results, Reinforcing Buy Rating
PremiumRatingsOpus Genetics’ Ryzumvi Shows Promising Phase 3 Results, Reinforcing Buy Rating
3M ago
Opus Genetics says LYNX-2 trial met primary endpoint
Premium
The Fly
Opus Genetics says LYNX-2 trial met primary endpoint
3M ago
Opus Genetics’ Promising Gene Therapy Advances and Strategic Partnerships Reinforce Buy Rating
Premium
Ratings
Opus Genetics’ Promising Gene Therapy Advances and Strategic Partnerships Reinforce Buy Rating
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100